Advanced search
Publication Cover
Expert Review of Hematology Volume 11, 2018 - Issue 3
Submit an article Journal homepage
984
Views
3
CrossRef citations to date
0
Altmetric
Review

Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?

Benjamin L. LampsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
&
Jennifer R. BrownDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]
View further author information
Pages 185-194 | Received 27 Nov 2017, Accepted 29 Jan 2018, Published online: 12 Feb 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Paweł Robak, Magda Witkowska, Anna Wolska-Washer & Tadeusz Robak. (2023) The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies. Expert Opinion on Drug Discovery 18:10, pages 1065-1076.
Read now
Barina Aqil, Amandeep Kaur, Josean Ramos, Madina Sukhanova, Shuo Ma, Juehua Gao, Xinyan Lu, Yi-Hua Chen & Qing Chen. (2023) Richter transformation to aggressive plasmablastic neoplasm related to selection of a BTK-mutated clone in a patient with CLL/SLL treated by ibrutinib. Leukemia & Lymphoma 64:1, pages 242-245.
Read now
Fortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, Cirino Botta, Mamdouh Skafi, Mohammed Abu-Rayyan, Moien Atrash, Sara Galimberti, Lucio Morabito, Hamdi Al-Janazreh, Massimo Martino, Giovanna Cutrona & Massimo Gentile. (2020) An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Expert Opinion on Pharmacotherapy 21:1, pages 29-38.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.